Affiliation:
1. From the Departments of Pharmacology and Medicine, Center for Clinical Pharmacology, University of Pittsburgh, School of Medicine, Pa.
Abstract
Dipeptidyl peptidase IV converts neuropeptide Y
1-36
(Y
1
-receptor agonist released from renal sympathetic nerves) to neuropeptide Y
3-36
(selective Y
2
-receptor agonist). Previous studies suggest that Y
1
, but not Y
2
, receptors enhance renovascular responses to angiotensin II in kidneys from genetically-susceptible animals. Therefore, we hypothesized that inhibition of dipeptidyl peptidase IV with sitagliptin (antidiabetic drug) would augment the ability of exogenous and endogenous neuropeptide Y
1-36
to enhance renal vascular responses to angiotensin II in kidneys from spontaneously hypertensive rats. This hypothesis was tested using 3 protocols in isolated perfused kidneys. Results from Protocol 1: Exogenous neuropeptide Y
1-36
enhanced renovascular responses to angiotensin II. This effect of neuropeptide Y
1-36
was blocked by BIBP3226 (selective Y
1
receptor antagonist); Exogenous neuropeptide Y
3-36
did not enhance renovascular responses to angiotensin II. Results from Protocol 2: Sitagliptin augmented the ability of exogenous neuropeptide Y
1-36
to enhance renovascular responses to angiotensin II. This effect of sitagliptin was blocked by BIBP3226. Results from Protocol 3: Renal sympathetic nerve stimulation enhanced renovascular responses to angiotensin II; this enhancement was augmented by sitagliptin and abolished by BIBP3226. Neuropeptide Y
1-36
via Y
1
receptors enhances renovascular responses to angiotensin II in kidneys from genetically hypertensive animals. Sitagliptin, by blocking dipeptidyl peptidase IV, prevents metabolism of neuropeptide Y
1-36
and thereby increases the effects of neuropeptide Y
1-36
released from renal sympathetic nerves on Y
1
receptors leading to augmentation of neuropeptide Y
1-36
–induced enhancement of the renovascular effects of angiotensin II. The renal effects of dipeptidyl peptidase IV inhibitors in hypertensive diabetic patients merit a closer examination.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Cited by
49 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献